ACTION: Improving breast cancer treatment adherence content
For many reasons (e.g. side effects, treatment beliefs), women with breast cancer struggle to adhere to adjuvant (post-treatment) hormonal therapy (HT). This is problematic because non-adherence increases risk of mortality.
In this programme we will co-develop, with women taking HTs and NHS clinicians, a brief psychological intervention that will be delivered to women with breast cancer after they have finished their active cancer treatment. This intervention aims to improve adherence to HTs and improve quality of life.
There will then be a small preliminary trial of this intervention to see whether it should be tested further in a larger definitive trial.
Lead researcher
Dr Samuel Smith
Cancer Research UK Postdoctoral Fellow, Queen Mary University of London
Dr Christopher Graham
University Academic Fellow in Behavioural Medicine & Clinical Psychologist, Queen's University Belfast
Every 17 minutes someone is diagnosed with cancer in Yorkshire
Our aim is for more people to survive cancer, here in Yorkshire and beyond.
Please help us continue to fund life-saving research.